Oyster Point Pharma, Inc. Lessee, Operating Lease, Liability, to be Paid
Oyster Point Pharma, Inc. had Lessee, Operating Lease, Liability, to be Paid of $2.72 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2022-11-10
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid $2.72M.
- 2022-06-30: Lessee, Operating Lease, Liability, to be Paid $2.94M.
- 2022-03-31: Lessee, Operating Lease, Liability, to be Paid $2.96M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $3.23M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2022-09-30 | $2.72M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.94M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.96M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.23M 10-K · filed 2022-02-24 |
| 2021-09-30 | $661.00K 10-Q · filed 2021-11-04 |
| 2021-08-31 | $2.70M 10-K · filed 2022-02-24 |
| 2021-06-30 | $800.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $937.00K 10-Q · filed 2021-05-06 |
| 2021-02-28 | $1.60M 10-Q · filed 2021-11-04 |
| 2020-12-31 | $687.00K 10-K · filed 2021-02-18 |
| 2020-09-30 | $793.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $900.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $821.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $913.00K 10-Q · filed 2019-12-03 |
| 2018-12-31 | $66.00K 10-K · filed 2020-02-27 |